Advanced Search

Primary Care Coding Alert

Reader Questions:

Extra Documentation May Be Necessary for Unlisted J Code Payment

Published on Wed Jun 13, 2007

Question: The FP performs an IV infusion of diltiazem HCl, also known as Cardizem or Tiazac. Which J code should I report for the drug supply?

New Hampshire Subscriber
Answer: You should report J3490 (Unclassified drugs), unless your payer instructs otherwise, because no permanent HCPCS code has been assigned to diltiazem HCl.

Depending on which insurer is processing your claim, you may also need to submit documentation with your claim to show which drug you administered, how much you administered, and for what condition you used it.  -- Answers to You Be the Coder and Reader Questions reviewed by Kent J. Moore, manager of Health Care Financing and Delivery Systems for the American Academy of Family Physicians in Leawood, Kan.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Primary Care Coding Alert

View All